Glomerulonephritis News and Research

RSS
FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Research reveals presence of potential autoantigen in patients with aggressive kidney disease

Research reveals presence of potential autoantigen in patients with aggressive kidney disease

New treatment offers hope for kidney failure and transplant patients with rare disorder

New treatment offers hope for kidney failure and transplant patients with rare disorder

Scientists identify genetic clues to chronic kidney disease

Scientists identify genetic clues to chronic kidney disease

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Researchers discover strong genetic risk factor for IgA nephropathy

Researchers discover strong genetic risk factor for IgA nephropathy

Circulating protein predicts risk of chronic kidney disease

Circulating protein predicts risk of chronic kidney disease

Stem cell biology and gene-editing techniques offer hope for kidney regeneration

Stem cell biology and gene-editing techniques offer hope for kidney regeneration

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

NEFIGAN Trial of Nefecon for treatment of primary IgA nephropathy meets primary endpoint

NEFIGAN Trial of Nefecon for treatment of primary IgA nephropathy meets primary endpoint

Asian and Hispanic patients with lupus have lower mortality rates

Asian and Hispanic patients with lupus have lower mortality rates

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

Alere starts voluntary correction about use of Alere INRatio and INRatio 2 PT/INR Monitor system

Alere starts voluntary correction about use of Alere INRatio and INRatio 2 PT/INR Monitor system

Researchers discover second protein associated with membranous nephropathy

Researchers discover second protein associated with membranous nephropathy

Anthera Pharmaceuticals reports net loss of $7.0 million for third quarter 2014

Anthera Pharmaceuticals reports net loss of $7.0 million for third quarter 2014

Pharmalink’s core patents for Nefecon issued in United States, Europe, China and Hong Kong

Pharmalink’s core patents for Nefecon issued in United States, Europe, China and Hong Kong

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis